Periodic Reporting for period 1 - AID (Artificial Intelligent Dentistry for cost-efficient X-ray analysis and diagnosis)
Berichtszeitraum: 2019-12-01 bis 2020-02-29
Regulatory constraint analysis has resulted in regulatory strategy marketing of Promaton Apox as a Class 2 medical device and a GDPR compliance roadmap.
As a result of the work undertaken the strategic vision is confirmed and the business plan will be executed.